Back to results
US 10,821,274 B2Granted
Methods and devices for delivery of pharmaceutical agents within orifices of the body
AssigneeRDD Pharma Ltd.
InventorNir Barak
Life of this patent
Estimating the term…
Abstract
A device for drug delivery to an orifice of a subject, comprising a shell which is elastically stressed by an active pharmaceutical ingredient, said shell containing and being substantially impermeable to said active pharmaceutical ingredient, wherein said shell has at least one hole sized for in-vivo release of said active pharmaceutical ingredient as a result of elastic stressing.
Claims16
A drug release system comprising:
- a drug delivery device comprising:
- an elastic shell containing a pharmaceutical composition,
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier and an active pharmaceutical ingredient, wherein the carrier has a melting point in the range of from about 23° C. to about 37.5° C., such that the carrier exhibits properties of being in a solid state at a room temperature and in a liquid state at a human body temperature,
- wherein the shell has an upper end, sides, and a lower portion with an aperture, the upper end and sides impermeable to the active pharmaceutical ingredient, and
- wherein the shell is elastically stressed by the pharmaceutical composition in the solid state to a degree of expansion that is at least 110% expansion as compared to an unstressed condition of the shell;
- and
- an elongated tail extending from the shell, the elongated tail being impermeable to the active pharmaceutical ingredient and having a plurality of holes for releasing the active pharmaceutical ingredient, wherein each hole of the plurality of holes has a size and is arranged in a predetermined pattern along the elongated tail;
- and
- a delivery element configured to deliver the elastically stressed shell into an orifice of a body, wherein the elastic shell and the pharmaceutical composition, in combination with one another, are configured such that elastic contraction of the shell forces the carrier in the liquid state and the active pharmaceutical ingredient to exit the delivery device through the plurality of holes of the elongated tail at a controlled rate of release, and wherein the controlled rate of release is at least partially controlled by one or more of:
- the degree of expansion of the shell under pressure, the elastic contraction of the shell after insertion, the viscosity of the pharmaceutical composition, the size of the holes, and the predetermined pattern of the plurality of holes.
7 more elements
Dependencies are inferred from the claim text.